Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Croft

Showing results (181-190 of 225) with videos related to

Pageof 23
Sort By:
JMIR Formative Research|January 25, 2021
Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and AssessmentMattias Neyt, Annick Christiaens, Marina Aloi, et al.
Immunological Reviews|October 1, 1991
Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their developmentS L Swain, L M Bradley, M Croft, et al.
Human Molecular Genetics|May 27, 2020
Ovotesticular disorders of sex development in FGF9 mouse models of human synostosis syndromesAnthony D Bird, Brittany M Croft, Masayo Harada, et al.
Inflammatory Bowel Diseases|May 24, 2011
Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel diseaseJames R Goodhand, Nikolasos Kamperidis, Arati Rao, et al.
Inorganic Chemistry|October 27, 2012
Magnetic and structural studies of the multifunctional material SrFe(0.75)Mo(0.25)O(3-δ)M Retuerto, M-R Li, Y B Go, et al.
Alimentary Pharmacology & Therapeutics|March 13, 2012
The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descentJ R Goodhand, N Kamperidis, N M Joshi, et al.
BMJ Open|July 3, 2020
Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease courseRachel E Harris, Marina Aloi, Lissy de Ridder, et al.
Journal of Crohn'S & Colitis|November 27, 2023
Improved Clinical Outcomes With Early Anti-Tumour Necrosis Factor Alpha Therapy in Children With Newly Diagnosed Crohn's Disease: Real-world Data from the International Prospective PIBD-SETQuality Inception Cohort StudyRenz C W Klomberg, Hella C van der Wal, Martine A Aardoom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2010
Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleEAnna Vossenkämper, Olivier Marchès, Peter D Fairclough, et al.
Gut|February 13, 2021
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemicColleen Gc McGregor, Alex Adams, Ross Sadler, et al.
Pageof 23

Showing results (181-190 of 225) with videos related to

Sort By:
Pageof 23
JMIR Formative Research|January 25, 2021
Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and AssessmentMattias Neyt, Annick Christiaens, Marina Aloi, et al.
Immunological Reviews|October 1, 1991
Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their developmentS L Swain, L M Bradley, M Croft, et al.
Human Molecular Genetics|May 27, 2020
Ovotesticular disorders of sex development in FGF9 mouse models of human synostosis syndromesAnthony D Bird, Brittany M Croft, Masayo Harada, et al.
Inflammatory Bowel Diseases|May 24, 2011
Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel diseaseJames R Goodhand, Nikolasos Kamperidis, Arati Rao, et al.
Inorganic Chemistry|October 27, 2012
Magnetic and structural studies of the multifunctional material SrFe(0.75)Mo(0.25)O(3-δ)M Retuerto, M-R Li, Y B Go, et al.
Alimentary Pharmacology & Therapeutics|March 13, 2012
The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descentJ R Goodhand, N Kamperidis, N M Joshi, et al.
BMJ Open|July 3, 2020
Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease courseRachel E Harris, Marina Aloi, Lissy de Ridder, et al.
Journal of Crohn'S & Colitis|November 27, 2023
Improved Clinical Outcomes With Early Anti-Tumour Necrosis Factor Alpha Therapy in Children With Newly Diagnosed Crohn's Disease: Real-world Data from the International Prospective PIBD-SETQuality Inception Cohort StudyRenz C W Klomberg, Hella C van der Wal, Martine A Aardoom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2010
Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleEAnna Vossenkämper, Olivier Marchès, Peter D Fairclough, et al.
Gut|February 13, 2021
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemicColleen Gc McGregor, Alex Adams, Ross Sadler, et al.
Pageof 23